|
Company
that speaks
Bad publicity received by pharmaceutical companies across
the world is making the industry sit up. Can a booster shot
of increased consumer and media interaction solve the problem,
wonders Ranjit Shahani, Vice-Chairman and Managing Director
Novartis and the President of OPPI.
In
the fast lane
Dr Kiran Mazumdar-Shaw, the Chairman and Managing Director
of Biocon talks on India's intrinsic strengths in the biotech
space, the robustness of sector and the challenges that need
to be addressed.
Taming
the dragon
China is considered to be India's biggest competitor in the
pharma space. However, it also represents a good and a viable
market full of opportunities. Malvinder Singh, the CEO of
Ranbaxy talks of the company's China venture.
A
conqueror's guide to business
DRL’s acquisition of betapharm has redefined the reach
of Indian pharma. Building scale is one way to become a global
player, writes Satish Reddy, MD and Chief Operating Officer
of Dr Reddy's Laboratories.
Adding
value through IPR
A good IPR system can have a manifold effect on innovation,
R&D and public health, writes Dr Ajit Dangi, Director
General, Organisation of Pharmaceutical Producers of India
(OPPI).
Focus
pharma
Utkarsh Palnitkar, Industry Leader, Health Sciences practice
of Ernst & Young assesses opportunities and challenges
in the Indian pharmaceutical industry.
Partnering
to success
Indian pharma is inching ahead in the global race by buying
their way out of hurdles. Hitesh Gajaria, Pharmaceutical Sector
Leader, KPMG talks about M&A trend in the pharma industry.
Six
mantras for seeking private equity
For all those seeking private equity investments, here are
six simple spells by Sanjiv D Kaul, Managing Director, ChrysCapital
to make investments 'easy to get'.
‘Tax’ing
Indian pharma
Jayant Jain, Associate Director and Dharmesh Panchal, Principal
Consultant, PricewaterhouseCoopers (PwC) discuss the benefits
and disadvantages of the Indian taxation system in context
of the pharma industry.
Stem
cell research: The Indian perspective
Slowly but steadily, stem cells are trickling down the pharma
research avenue. Dr Alka Sharma, Principal Scientific Officer,
Department of Biotechnology, Ministry of Science & Technology,
Government of India, does a status check on stem cell research
in India.
Innovator's
dilemma
A number of Indian companies have started embracing drug discovery.
However, Indian policies needs to evolve parallely with these
developments, writes Dr Sudarshan Arora, President NCE Research,
Lupin.
The
CRO story
It is boom time for CROs. Yet, there are quite a few issues
that are to be kept in mind like ethics, reputation and IPR,
asserts Dr Vasudeo Ginde, President and Managing Director,
iGATE Clinical Research International.
What
they don't teach at research institutes
Dr K G Rajendran, Head, Knowledge Cell USV talks about the
necessity to teach about the scientific conduct, medical ethics
and soft skills in universities.
People
assets—Are we on track?
A roadblock to the Indian pharma success story could be diminishing
human resources, opines Dr Gopakumar G Nair, Patent Attorney
and the CEO of Gopakumar Nair Associates.
Indian
CROs—cost or quality?
Indian CROs have to deal with the accusation of losing out
on quality in their desire to be competitive. Dr Mary Francis,
CEO, Ace Biomed talks about the quality levels of Indian CROs.
A
trip down 'medicine avenue'
Asha Kapoor, Exceutive Director, Sudler & Hennessey shares
her personal experiences on pharma branding and marketing.
Optimising
drug discovery
George Varghese, Director-Pharma, ITeS and mid-markets for
SAS India writes on how IT can help the process of drug discovery.
Pharma
logs into the IT mode
Information technology can help hasten the Indian pharmaceutical
revolution, writes Micheal Kirby, Industry Solution Director,
Oracle Asia Pacific.
The
year that was
Stars
shine down!
The Sixth Pharma Excellence Awards conducted by Express Pharma,
in association with Ernst & Young, was an event to remember
with the who's who of the pharma fraternity attending it on
May 26, 2006.
Behind
the Scenes
|
